Singapore markets close in 3 hours 43 minutes

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4210+0.0100 (+2.43%)
At close: 04:00PM EDT
0.4153 -0.01 (-1.35%)
After hours: 05:34PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.4110
Open0.4114
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.4000 - 0.4467
52-week range0.3900 - 4.8000
Volume58,233
Avg. volume239,731
Market cap1.579M
Beta (5Y monthly)0.96
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

    PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today reported that it received a notice (the “Notice) on April 4, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to file its Annual Report on Form 10-K for the fisc

  • GlobeNewswire

    Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance

    ACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as its new Vice President - Finance. In her new role, Ms. Mehalik will assume responsibility for directing and managing all financial activities at Psychemedics, including comprehensive oversight of external reporting and internal analysis. Reporting directly to CEO and President Brian Hullinger, she wil

  • CNW Group

    SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE

    Today, Symetryx Corporation ("Symetryx") announced that it has acquired 20% of the issued and outstanding common stock in Neubase Therapeutics Inc. (NASDAQ: NBSE) ("Neubase"). Symetryx is now urging the Board to issue a special $1 per share dividend.